Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

The association of profilin-1 levels with survival in chronic kidney disease.

Eroglu E, Unal HU, Guclu A, Kocyigit I, Karaman M, Saglam M, Gezer M, Tas A, Zararsiz G, Eyileten T, Aydin İ, Oguz Y, Gungor O, Yilmaz MI.

Eur J Clin Invest. 2017 Dec;47(12). doi: 10.1111/eci.12839. Epub 2017 Oct 27.

PMID:
28981140
2.

IL-33 and ST2 levels in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events, and survival.

Gungor O, Unal HU, Guclu A, Gezer M, Eyileten T, Guzel FB, Altunoren O, Erken E, Oguz Y, Kocyigit I, Yilmaz MI.

PLoS One. 2017 Jun 14;12(6):e0178939. doi: 10.1371/journal.pone.0178939. eCollection 2017.

3.

Hormonal changes in hemodialysis patients: Novel risk factors for mortality?

Gungor O, Kocyigit I, Carrero JJ, Yılmaz MI.

Semin Dial. 2017 Sep;30(5):446-452. doi: 10.1111/sdi.12611. Epub 2017 Jun 13. Review.

PMID:
28608932
4.

Role of vascular calcification inhibitors in preventing vascular dysfunction and mortality in hemodialysis patients.

Gungor O, Kocyigit I, Yilmaz MI, Sezer S.

Semin Dial. 2018 Jan;31(1):72-81. doi: 10.1111/sdi.12616. Epub 2017 Jun 13. Review.

PMID:
28608927
5.

Effect of testosterone replacement therapy on vitamin D and FGF-23 levels in congenital hypogonadism.

Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Taslipinar A, Yilmaz MI, Azal O.

Endokrynol Pol. 2017;68(3):311-616. doi: 10.5603/EP.a2017.0009. Epub 2017 Feb 23.

6.

Visceral adiposity index and triglyceride/high-density lipoprotein cholesterol ratio in hypogonadism.

Haymana C, Sonmez A, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O.

Arch Endocrinol Metab. 2017 May-Jun;61(3):282-287. doi: 10.1590/2359-3997000000236. Epub 2017 Feb 13.

7.

The Prevalence of Fabry Disease in Patients with Chronic Kidney Disease in Turkey: The TURKFAB Study.

Turkmen K, Guclu A, Sahin G, Kocyigit I, Demirtas L, Erdur FM, Sengül E, Ozkan O, Emre H, Turgut F, Unal H, Karaman M, Acıkel C, Esen H, Balli E, Bıtırgen G, Tonbul HZ, Yılmaz MI, Ortiz A.

Kidney Blood Press Res. 2016;41(6):1016-1024. doi: 10.1159/000452605. Epub 2016 Dec 23.

8.

Colchicine in Renal Medicine: New Virtues of an Ancient Friend.

Solak Y, Siriopol D, Yildiz A, Yilmaz MI, Ortiz A, Covic A, Kanbay M.

Blood Purif. 2017;43(1-3):125-135. doi: 10.1159/000454669. Epub 2016 Dec 13. Review.

9.

Vasopressin-related copeptin is a novel predictor of early endothelial dysfunction in patients with adult polycystic kidney disease.

Kocyigit I, Yilmaz MI, Gungor O, Eroglu E, Unal A, Orscelik O, Tokgoz B, Sipahioglu M, Sen A, Carrero JJ, Oymak O, Axelsson J.

BMC Nephrol. 2016 Nov 30;17(1):196.

10.

Investigation of the knowledge and attitudes of patients who are undergoing hemodialysis treatment regarding their arteriovenous fistula.

Ozen N, Tosun N, Cinar FI, Bagcivan G, Yilmaz MI, Askin D, Mut D, Ozen V, Yenicesu M, Zajm E.

J Vasc Access. 2017 Jan 18;18(1):64-68. doi: 10.5301/jva.5000618. Epub 2016 Nov 3.

PMID:
27834457
11.

Endostatin in chronic kidney disease: Associations with inflammation, vascular abnormalities, cardiovascular events and survival.

Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Gezer M, Taş A, Eyileten T, Guler AK, Aydin İ, Oguz Y, Tarim K, Covic A, Yilmaz MI.

Eur J Intern Med. 2016 Sep;33:81-7. doi: 10.1016/j.ejim.2016.06.033. Epub 2016 Jul 7.

PMID:
27394925
12.

Chitotriosidase as a novel biomarker of early atherosclerosis in hemodialysis patients.

Güçlü A, Yilmaz MI, Tokmak TT, Unal HU, Karaman M, Gezer M, Taş A, Aydin İ, Akçılar R, Dursun Y.

Hemodial Int. 2017 Jan;21(1):41-46. doi: 10.1111/hdi.12451. Epub 2016 Jul 4.

PMID:
27378685
13.

Nebivolol and Endothelial Dysfunction in Patients With Essential Hypertension: A Reputation Saver of β-Blockers?

Celik T, Ozturk C, Balta S, Yilmaz MI.

J Clin Hypertens (Greenwich). 2016 Dec;18(12):1258-1259. doi: 10.1111/jch.12856. Epub 2016 Jun 1. No abstract available.

14.

Thyroid function and cardiovascular events in chronic kidney disease patients.

Afsar B, Yilmaz MI, Siriopol D, Unal HU, Saglam M, Karaman M, Gezer M, Sonmez A, Eyileten T, Aydin I, Hamcan S, Oguz Y, Covic A, Kanbay M.

J Nephrol. 2017 Apr;30(2):235-242. doi: 10.1007/s40620-016-0300-y. Epub 2016 Apr 2.

PMID:
27039198
15.

Osteoprotegerin in Chronic Kidney Disease: Associations with Vascular Damage and Cardiovascular Events.

Yilmaz MI, Siriopol D, Saglam M, Unal HU, Karaman M, Gezer M, Kilinc A, Eyileten T, Guler AK, Aydin İ, Vural A, Oguz Y, Covic A, Ortiz A, Kanbay M.

Calcif Tissue Int. 2016 Aug;99(2):121-30. doi: 10.1007/s00223-016-0136-4. Epub 2016 Mar 26.

PMID:
27016924
16.

Relevance of uric acid and asymmetric dimethylarginine for modeling cardiovascular risk prediction in chronic kidney disease patients.

Kanbay M, Afsar B, Siriopol D, Unal HU, Karaman M, Saglam M, Eyileten T, Gezer M, Verim S, Oguz Y, Vural A, Ortiz A, Johnson RJ, Covic A, Yilmaz MI.

Int Urol Nephrol. 2016 Jul;48(7):1129-36. doi: 10.1007/s11255-016-1271-6. Epub 2016 Mar 23.

PMID:
27007614
17.

The Relationship Between Plasma Whole Blood Viscosity and Cardiovascular Events in Patients With Chronic Kidney Disease.

Celik T, Yilmaz MI, Balta S, Ozturk C, Unal HU, Aparci M, Karaman M, Demir M, Yildirim AO, Saglam M, Kilic S, Eyileten T, Aydin İ, Iyisoy A.

Clin Appl Thromb Hemost. 2017 Sep;23(6):663-670. doi: 10.1177/1076029616634888. Epub 2016 Feb 22.

PMID:
26907084
18.

Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Siriopol D, Saglam M, Unal HU, Yaman H, Gok M, Cetinkaya H, Gaipov A, Eyileten T, Sari S, Yildirim AO, Tonbul HZ, Turk S, Covic A, Kanbay M.

Int Urol Nephrol. 2015 Dec;47(12):1993-2001. doi: 10.1007/s11255-015-1136-4. Epub 2015 Oct 26.

PMID:
26498629
19.

Predictive Value of Atrial Electromechanical Delay on Long-Term Cardiovascular Outcomes in Hemodialysis Patients.

Turkmen K, Demirtas L, Topal E, Gaipov A, Kocyigit I, Orscelik O, Guney I, Kılıc S, Yilmaz MI.

Am J Nephrol. 2015;42(3):239-49. doi: 10.1159/000441099. Epub 2015 Oct 20.

PMID:
26484658
20.

Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement.

Sonmez A, Haymana C, Aydogdu A, Tapan S, Basaran Y, Meric C, Baskoy K, Dinc M, Yazici M, Taslipinar A, Barcin C, Yilmaz MI, Bolu E, Azal O.

Endocr J. 2015;62(7):605-13. doi: 10.1507/endocrj.EJ15-0125. Epub 2015 May 28.

21.

The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease.

Sonmez A, Yilmaz MI, Saglam M, Unal HU, Gok M, Cetinkaya H, Karaman M, Haymana C, Eyileten T, Oguz Y, Vural A, Rizzo M, Toth PP.

Lipids Health Dis. 2015 Apr 16;14:29. doi: 10.1186/s12944-015-0031-4.

22.

Blood pressure control in patients with hypertension: a retrospective cohort study.

Aydogan U, Doganer YC, Atik A, Rohrer JE, Engin Gok D, Cirpan E, Yilmaz MI, Saglam K.

J Eval Clin Pract. 2015 Apr;21(2):313-9. doi: 10.1111/jep.12318. Epub 2015 Feb 6.

PMID:
25659424
23.

A longitudinal study of inflammation, CKD-mineral bone disorder, and carotid atherosclerosis after renal transplantation.

Yilmaz MI, Sonmez A, Saglam M, Cayci T, Kilic S, Unal HU, Karaman M, Cetinkaya H, Eyileten T, Gok M, Oguz Y, Vural A, Mallamaci F, Zoccali C.

Clin J Am Soc Nephrol. 2015 Mar 6;10(3):471-9. doi: 10.2215/CJN.07860814. Epub 2014 Dec 26.

24.

Endocan, a novel marker of endothelial dysfunction in patients with essential hypertension: comparative effects of amlodipine and valsartan.

Celık T, Balta S, Karaman M, Ahmet Ay S, Demırkol S, Ozturk C, Dınc M, Unal HU, Yılmaz MI, Kılıc S, Kurt G, Tas A, Iyısoy A, Quartı-Trevano F, Fıcı F, Grassı G.

Blood Press. 2015 Feb;24(1):55-60. doi: 10.3109/08037051.2014.972816. Epub 2014 Nov 12.

PMID:
25390761
25.

Ramipril lowers plasma FGF-23 in patients with diabetic nephropathy.

Yilmaz MI, Sonmez A, Saglam M, Kurt YG, Unal HU, Karaman M, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Vural A, Mallamaci F, Zoccali C.

Am J Nephrol. 2014;40(3):208-14. doi: 10.1159/000366169. Epub 2014 Oct 10.

26.

Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease.

Unal HU, Çelik M, Gökoğlan Y, Çetinkaya H, Gök M, Karaman M, Yilmaz Mİ, Eyileten T, Oğuz Y.

Ren Fail. 2014 Nov;36(10):1481-5. doi: 10.3109/0886022X.2014.962421. Epub 2014 Sep 16.

PMID:
25224152
27.

Competitive interaction between fibroblast growth factor 23 and asymmetric dimethylarginine in patients with CKD.

Tripepi G, Kollerits B, Leonardis D, Yilmaz MI, Postorino M, Fliser D, Mallamaci F, Kronenberg F, Zoccali C.

J Am Soc Nephrol. 2015 Apr;26(4):935-44. doi: 10.1681/ASN.2013121355. Epub 2014 Aug 22.

28.

Serum sclerostin and adverse outcomes in nondialyzed chronic kidney disease patients.

Kanbay M, Siriopol D, Saglam M, Kurt YG, Gok M, Cetinkaya H, Karaman M, Unal HU, Oguz Y, Sari S, Eyileten T, Goldsmith D, Vural A, Veisa G, Covic A, Yilmaz MI.

J Clin Endocrinol Metab. 2014 Oct;99(10):E1854-61. doi: 10.1210/jc.2014-2042. Epub 2014 Jul 24.

PMID:
25057883
29.

Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease.

Yilmaz MI, Siriopol D, Saglam M, Kurt YG, Unal HU, Eyileten T, Gok M, Cetinkaya H, Oguz Y, Sari S, Vural A, Mititiuc I, Covic A, Kanbay M.

Kidney Int. 2014 Dec;86(6):1213-20. doi: 10.1038/ki.2014.227. Epub 2014 Jul 2.

30.

Endothelial function in patients with familial Mediterranean fever-related amyloidosis and association with cardiovascular events.

Yilmaz MI, Demirkaya E, Acikel C, Saldir M, Akar S, Cayci T, Saglam M, Unal HU, Gok M, Polat A, Cetinkaya H, Eyileten T, Sari S, Yildirim AO, Sonmez A, Oguz Y, Vural A, Ozen S, Carrero JJ.

Rheumatology (Oxford). 2014 Nov;53(11):2002-8. doi: 10.1093/rheumatology/keu231. Epub 2014 Jun 6.

PMID:
24907154
31.

Monocyte count/HDL cholesterol ratio and cardiovascular events in patients with chronic kidney disease.

Kanbay M, Solak Y, Unal HU, Kurt YG, Gok M, Cetinkaya H, Karaman M, Oguz Y, Eyileten T, Vural A, Covic A, Goldsmith D, Turak O, Yilmaz MI.

Int Urol Nephrol. 2014 Aug;46(8):1619-25. doi: 10.1007/s11255-014-0730-1. Epub 2014 May 23.

PMID:
24853998
32.

The relationship between IL-10 levels and cardiovascular events in patients with CKD.

Yilmaz MI, Solak Y, Saglam M, Cayci T, Acikel C, Unal HU, Eyileten T, Oguz Y, Sari S, Carrero JJ, Stenvinkel P, Covic A, Kanbay M.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1207-16. doi: 10.2215/CJN.08660813. Epub 2014 May 1.

33.

Soluble TWEAK plasma levels increase after renal transplantation and associate with the improvement of endothelial function.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Sari S, Yildirim AO, Vural A, Carrero JJ, Blanco-Colio LM.

Eur J Clin Invest. 2013 Dec;43(12):1250-7. doi: 10.1111/eci.12166. Epub 2013 Sep 20.

PMID:
24112080
34.

A link between the intrarenal renin angiotensin system and hypertension in autosomal dominant polycystic kidney disease.

Kocyigit I, Yilmaz MI, Unal A, Ozturk F, Eroglu E, Yazici C, Orscelik O, Sipahioglu MH, Tokgoz B, Oymak O.

Am J Nephrol. 2013;38(3):218-25. doi: 10.1159/000354317. Epub 2013 Aug 28.

PMID:
23988725
35.

Red cell distribution width is independently related to endothelial dysfunction in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Saglam M, Caglar K, Verim S, Unal HU, Gok M, Demirkaya E, Gaipov A, Kayrak M, Cetinkaya H, Eyileten T, Turk S, Vural A.

Am J Med Sci. 2014 Feb;347(2):118-24. doi: 10.1097/MAJ.0b013e3182996a96.

PMID:
23928544
36.

Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.

Kocyigit I, Yilmaz MI, Orscelik O, Sipahioglu MH, Unal A, Eroglu E, Kalay N, Tokgoz B, Axelsson J, Oymak O.

Nephron Clin Pract. 2013;123(3-4):157-64. doi: 10.1159/000353730. Epub 2013 Jul 25.

PMID:
23887359
37.

Mean corpuscular volume is associated with endothelial dysfunction and predicts composite cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Saglam M, Demirbas S, Verim S, Unal HU, Gaipov A, Oguz Y, Kayrak M, Caglar K, Vural A, Turk S, Covic A, Kanbay M.

Nephrology (Carlton). 2013 Nov;18(11):728-35. doi: 10.1111/nep.12130.

PMID:
23848392
38.

FGF23: a mature renal and cardiovascular risk factor?

Zoccali C, Yilmaz MI, Mallamaci F.

Blood Purif. 2013;36(1):52-7. doi: 10.1159/000351001. Epub 2013 May 25. Review.

PMID:
23735695
39.

Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation.

Yilmaz MI, Sonmez A, Saglam M, Yaman H, Kilic S, Turker T, Unal HU, Gok M, Cetinkaya H, Eyileten T, Oguz Y, Caglar K, Vural A, Mallamaci F, Zoccali C.

Am J Nephrol. 2013;37(2):126-34. doi: 10.1159/000346711. Epub 2013 Jan 31.

PMID:
23391995
40.

Serum gamma-glutamyltransferase levels are inversely related to endothelial function in chronic kidney disease.

Yilmaz MI, Turgut F, Kanbay M, Saglam M, Sonmez A, Yaman H, Demirbas S, Unal HU, Gok M, Karaman M, Ay SA, Demirkaya E, Covic A, Carrero JJ.

Int Urol Nephrol. 2013 Aug;45(4):1071-8. doi: 10.1007/s11255-012-0354-2. Epub 2012 Dec 15.

PMID:
23242503
41.

Neutrophil to lymphocyte ratio independently predicts cardiovascular events in patients with chronic kidney disease.

Solak Y, Yilmaz MI, Sonmez A, Saglam M, Cakir E, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Karaman M, Ay SA, Gaipov A, Turk S, Vural A, Carrero JJ.

Clin Exp Nephrol. 2013 Aug;17(4):532-40. doi: 10.1007/s10157-012-0728-x. Epub 2012 Nov 20.

PMID:
23180042
42.

To study the correlation between carrier status of nasal Staphylococcus aureus in patients on haemodialysis with hepatitis C, hepatitis B and their sociodemographic features.

Aydogan U, Akbulut H, Gok DE, Yilmaz MI, Yuksel S, Sari O, Doganer YC, Senses Z, Baltaci D, Kara IH, Saglam K, Qidwai W, Waheed S.

West Indian Med J. 2012 Mar;61(2):139-44.

PMID:
23155958
43.

The role of platelet activation in determining response to therapy in patients with primary nephrotic syndrome.

Kocyigit I, Yilmaz MI, Simşek Y, Unal A, Sipahioglu MH, Eroglu E, Dede F, Tokgoz B, Oymak O, Utas C.

Platelets. 2013;24(6):474-9. doi: 10.3109/09537104.2012.731111. Epub 2012 Nov 13.

PMID:
23148780
44.

Serum uric acid independently predicts cardiovascular events in advanced nephropathy.

Kanbay M, Yilmaz MI, Sonmez A, Solak Y, Saglam M, Cakir E, Unal HU, Arslan E, Verim S, Madero M, Caglar K, Oguz Y, McFann K, Johnson RJ.

Am J Nephrol. 2012;36(4):324-31. doi: 10.1159/000342390. Epub 2012 Sep 22.

45.

Peri-aortic fat tissue and malnutrition-inflammation-atherosclerosis/calcification syndrome in end-stage renal disease patients.

Turkmen K, Tonbul HZ, Erdur FM, Guney I, Kayikcioglu H, Altintepe L, Ozbek O, Yilmaz MI, Gaipov A, Turk S, Covic A, Kanbay M.

Int Urol Nephrol. 2013 Jun;45(3):857-67. doi: 10.1007/s11255-012-0286-x. Epub 2012 Sep 23.

PMID:
23001639
46.

Relationship between serum magnesium levels and cardiovascular events in chronic kidney disease patients.

Kanbay M, Yilmaz MI, Apetrii M, Saglam M, Yaman H, Unal HU, Gok M, Caglar K, Oguz Y, Yenicesu M, Cetinkaya H, Eyileten T, Acikel C, Vural A, Covic A.

Am J Nephrol. 2012;36(3):228-37. Epub 2012 Aug 30.

PMID:
22948239
47.

Early arterial stiffness and inflammatory bio-markers in normotensive polycystic kidney disease patients.

Kocyigit I, Kaya MG, Orscelik O, Kaya C, Akpek M, Zengin H, Sipahioglu MH, Unal A, Yilmaz MI, Tokgoz B, Oymak O, Axelsson J.

Am J Nephrol. 2012;36(1):11-8. doi: 10.1159/000339440. Epub 2012 Jun 13.

PMID:
22699414
48.

Dialysis type may predict carotid intima media thickness and plaque presence in end-stage renal disease patients.

Mutluay R, Degertekin CK, Poyraz F, Yılmaz MI, Yücel C, Turfan M, Tavil Y, Derici Ü, Arınsoy T, Sindel S.

Adv Ther. 2012 Apr;29(4):370-82. doi: 10.1007/s12325-012-0011-2. Epub 2012 Mar 30.

PMID:
22467434
49.

Serum calcitonin and endothelial dysfunction in chronic kidney disease: a novel risk factor?

Kanbay M, Yilmaz MI, Afsar B, Saglam M, Akgul EO, Cayci T, Caglar K, Unal HU, Gok M, Vural A, Covic A.

Int Urol Nephrol. 2013 Feb;45(1):151-6. doi: 10.1007/s11255-012-0158-4. Epub 2012 Mar 23.

PMID:
22437807
50.

Supplemental Content

Loading ...
Support Center